155 related articles for article (PubMed ID: 34763634)
1. Acute coronary syndrome in patients with cancer: features of the course and the possibility of predicting hospital and long-term (6 months) periods using GDF-15, NT-proBNP, hs-CRP biomarkers.
Shalenkova MA; Ivanov AV; Klimkin PF
Kardiologiia; 2021 Oct; 61(10):4-13. PubMed ID: 34763634
[TBL] [Abstract][Full Text] [Related]
2. Heart failure with preserved left ventricular ejection fraction in patients with obstructive sleep apnea syndrome: prognostic value of biomarkers.
Grakova EV; Yakovlev AV; Shilov SN; Berezikova EN; Kopeva KV; Yakovleva NF; Ogurkova ON; Teplyakov AT
Kardiologiia; 2021 Nov; 61(11):77-88. PubMed ID: 34882081
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of NT-proBNP in Patients With Successful PCI for ACS and Normal Left Ventricular Ejection Fraction.
Wang JL; Guo CY; Li HW; Zhao XQ; Zhao SM
Am J Med Sci; 2022 Apr; 363(4):333-341. PubMed ID: 34986361
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
[TBL] [Abstract][Full Text] [Related]
6. Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort.
Gürgöze MT; Akkerhuis KM; Oemrawsingh RM; Umans VAWM; Kietselaer B; Schotborgh CE; Ronner E; Lenderink T; Aksoy I; van der Harst P; Asselbergs FW; Maas AC; Oude Ophuis AJ; Krenning B; de Winter RJ; The SHK; Wardeh AJ; Hermans WRM; Cramer GE; van Gorp I; de Rijke YB; van Schaik RHN; Boersma E
Eur Heart J Acute Cardiovasc Care; 2023 Jul; 12(7):451-461. PubMed ID: 37096818
[TBL] [Abstract][Full Text] [Related]
7. Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study.
van den Berg VJ; Umans VAWM; Brankovic M; Oemrawsingh RM; Asselbergs FW; van der Harst P; Hoefer IE; Kietselaer B; Crijns HJGM; Lenderink T; Oude Ophuis AJ; van Schaik RH; Kardys I; Boersma E; Akkerhuis KM;
Clin Chem Lab Med; 2020 Nov; 58(12):2099-2106. PubMed ID: 32383686
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of acute cardiorenal syndrome in patients with acute cardiac pathology].
Mezhonov EM; Vyalkina JA; Shalaev SV
Kardiologiia; 2019 Sep; 59(8S):44-55. PubMed ID: 31526361
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
10. [NGAL as a marker for some extrarenal complications in acute coronary syndrome].
Shalenkova MA; Mikhailova ZD; Klimkin PF
Kardiologiia; 2018 SMar; (S3):19-26. PubMed ID: 29782286
[TBL] [Abstract][Full Text] [Related]
11. [The Prognostic Role of Biomarkers in Patients With Chronic Heart Failure].
Kurlianskaya EK; Mrochek AG; Denisevich TL; Kaliadka MG; Russkich II
Kardiologiia; 2020 Feb; 60(1):16-22. PubMed ID: 32245350
[TBL] [Abstract][Full Text] [Related]
12. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
[TBL] [Abstract][Full Text] [Related]
13. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of NT-proBNP versus Killip Classification in Patients with Acute Coronary Syndromes.
Souza TMB; Cerqueira AMS; Suerdieck JG; Sá NC; Sodré GS; Correia VCA; Lacerda YF; Fonseca LL; Noya-Rabelo MM; Correia LCL
Arq Bras Cardiol; 2020 Apr; 114(4):666-672. PubMed ID: 32074200
[TBL] [Abstract][Full Text] [Related]
15. THE ROLE OF NT-PROBNP AND ST2 BIOMARKERS IN PATIENTS WITH ACUTE CORONARY SYNDROME.
Barnett O; Halkevych M; Labinska O; Lutsiv N; Kyyak Y
Wiad Lek; 2022; 75(1):34-38. PubMed ID: 35092243
[TBL] [Abstract][Full Text] [Related]
16. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
17. Incremental prognostic value of C-reactive protein and N-terminal proB-type natriuretic peptide in acute coronary syndrome.
Kim H; Yang DH; Park Y; Han J; Lee H; Kang H; Park HS; Cho Y; Chae SC; Jun JE; Park WH
Circ J; 2006 Nov; 70(11):1379-84. PubMed ID: 17062957
[TBL] [Abstract][Full Text] [Related]
18. No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.
Poldervaart JM; Röttger E; Dekker MS; Zuithoff NP; Verheggen PW; de Vrey EA; Wildbergh TX; van 't Hof AW; Mosterd A; Hoes AW
PLoS One; 2015; 10(7):e0132000. PubMed ID: 26177390
[TBL] [Abstract][Full Text] [Related]
19. Predictive Value of the Lipoprotein(a) to Prealbumin Ratio and of the NT-proBNP to LVEF Ratio for Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.
Zhang Y; Shi F
Heart Surg Forum; 2023 Oct; 26(5):E470-E477. PubMed ID: 37920075
[TBL] [Abstract][Full Text] [Related]
20. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure.
Lok DJ; Klip IT; Lok SI; Bruggink-André de la Porte PW; Badings E; van Wijngaarden J; Voors AA; de Boer RA; van Veldhuisen DJ; van der Meer P
Am J Cardiol; 2013 Sep; 112(6):831-7. PubMed ID: 23820571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
